Torrent Pharma

Torrent Pharma Inc. (TPI) is the wholly-owned U.S. subsidiary of Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals Ltd is a leading pharmaceutical company in India, with a growing influence in the global generic drug market. Established in 2004, TPI currently has 64 FDA-approved generic products under commercial sale in the United States. Several of these products hold dominant market shares of 10% to 30% in their respective categories, including 14 products that rank among the top three.